SCI Abstract

search
Benefit–Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous Thromboembolism
Benefit–Risk Assessment of Rivaroxaban in Older Patients With Nonvalvular Atrial Fibrillation or Venous Thromboembolism
Both bleeding and adverse ischemic events increase with age, compounding the benefit–risk balance of anticoagulants ...
Management of Late-Onset Rheumatoid Arthritis with Treat-to-Target Strategy
Management of Late-Onset Rheumatoid Arthritis with Treat-to-Target Strategy
The incidence of patients with late-onset rheumatoid arthritis (LORA) is increasing. The clinical diagnosis of LORA is ess...
Treatment Considerations for Severe Osteoporosis in Older Adults
Treatment Considerations for Severe Osteoporosis in Older Adults
Osteoporosis, a chronic metabolic bone disease, increases the predisposition to fragility fractures and is associated with...
The Aging Patient with Cystic Fibrosis
The Aging Patient with Cystic Fibrosis
Cystic fibrosis (CF) is an inherited condition that leads to multiorgan dysfunction, especially in the respiratory, gastro...
Testosterone Therapy in Older Men: Present and Future Considerations
Testosterone Therapy in Older Men: Present and Future Considerations
Testosterone is the classical male anabolic hormone, involved in sexual development, virilisation and regulation of body c...
Risk Factors for Vancomycin-Induced Nephrotoxicity and Kidney Prognosis in Patients Aged 75 Years and Older: A Retrospective Study
Risk Factors for Vancomycin-Induced Nephrotoxicity and Kidney Prognosis in Patients Aged 75 Years and Older: A Retrospective Study
Whether risk factors for vancomycin-induced nephrotoxicity (VIN) development reported in recent years are also risk factor...
Managing Rheumatoid Arthritis in Older Adults with Cancer
Managing Rheumatoid Arthritis in Older Adults with Cancer
Rheumatoid arthritis (RA) is a chronic autoimmune condition disproportionately affecting older adults (> 60 years),...
Correction: Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options
Correction: Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options
Illustration of intravesical drug delivery via a transurethral catheter in female mice. Combined instillation of paramagne...
Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials
Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials
Insomnia is more common as people age. Several common hypnotics used to treat insomnia often do not adequately alleviate s...
Fall Outcomes in Older Adults Following Benzodiazepine/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System
Fall Outcomes in Older Adults Following Benzodiazepine/Z-Drug Discontinuation: A Retrospective Cohort Study in an Academic Health System
Benzodiazepines and z-drugs increase the fall risk in older adults. There is a lack of real-world data examining the assoc...
Prevalence of Adverse Drug Reactions in Hospital Among Older Patients with and Without Dementia
Prevalence of Adverse Drug Reactions in Hospital Among Older Patients with and Without Dementia
Older inpatients with dementia are at an increased risk of an adverse drug reaction (ADR) during hospitalization. To quant...
Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects
Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects
Corticosteroids play a crucial role as anti-inflammatory and immunomodulatory agents in dermatology and other medical spec...
Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia
Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia
As dementia progresses, people living with dementia may take high-risk, unnecessary, or ineffective medicines. Cholinester...
Minimising Harm and Managing Pain: Deprescribing Opioids in Older Adults
Minimising Harm and Managing Pain: Deprescribing Opioids in Older Adults
Approximately one in three older adults (aged 65 years and over) experience pain, negatively impacting their quality of li...
Pilocarpine in the Treatment of Presbyopia: Progress, Issues, and Future Prospects
Pilocarpine in the Treatment of Presbyopia: Progress, Issues, and Future Prospects
Presbyopia is a common age-related visual impairment. With the aging of the population, the incidence of presbyopia is inc...
Pharmacological Treatment of Obesity in Older Adults
Pharmacological Treatment of Obesity in Older Adults
Obesity is a complex health issue with growing prevalence worldwide. It is also becoming more prevalent in the population ...
Development of a Frailty Screening Tool Using Electronic Community Pharmacy Records
Development of a Frailty Screening Tool Using Electronic Community Pharmacy Records
Frailty is associated with increased susceptibility to medication-related harm, highlighting the importance of medication ...